Your browser doesn't support javascript.
loading
Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?
Demidova, Elena V; Ghatalia, Pooja; Arora, Sanjeevani.
Affiliation
  • Demidova EV; Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Kazan Federal University, Kazan, Russia.
  • Ghatalia P; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Arora S; Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: sanjeevani.arora@fccc.edu.
Eur Urol ; 81(2): 149-150, 2022 02.
Article in En | MEDLINE | ID: mdl-34753637
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Limits: Female / Humans / Male Language: En Journal: Eur Urol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Limits: Female / Humans / Male Language: En Journal: Eur Urol Year: 2022 Document type: Article Affiliation country: Country of publication: